NCT02588911

Brief Summary

The current study was a double blind randomised controlled trial that compared radiofrequency ablation (RFA) versus conventional surgery (CS) in patients who served as their own controls and who had intact great saphenous veins (GSVs).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

October 20, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 28, 2015

Completed
Last Updated

October 28, 2015

Status Verified

October 1, 2015

Enrollment Period

1.5 years

First QC Date

October 20, 2015

Last Update Submit

October 26, 2015

Conditions

Keywords

Radiofrequency Catheter AblationOperative Surgical ProcedureSaphenous Vein

Outcome Measures

Primary Outcomes (10)

  • Change in intensity of hyper pigmentation using a scale of 0 to 10

    Patients and physicians were oriented to indicate their subjective perception of intensity of hyperpigmentation on a scale of 0 (no complaint/discomfort) to 10 (maximal complaint/discomfort).

    One week, one month and six months after surgery

  • Change in extension of hematoma using a scale of 0 to 10

    Patients and physicians were oriented to indicate their subjective perception of extension of hematoma on a scale of 0 (no complaint/discomfort) to 10 (maximal complaint/discomfort).

    One week, one month and six months after surgery

  • Change in aesthetic results using a scale of 0 to 10

    Patients and physicians were oriented to indicate their subjective perception of aesthetic results on a scale of 0 (unaesthetic) to 10 (excellent results).

    One week, one month and six months after surgery

  • Change in pain levels using a scale of 0 to 10

    Patients were asked to indicate pain levels on a scale of 0 (no pain) to 10 (worst imaginable pain).

    One week, one month and six months after surgery

  • Change in intensity of skin burns using a scale of 0 to 10

    Physicians were asked to inform intensity of skin burns on a scale of 0 (no complaint/discomfort) to 10 (maximal complaint/discomfort).

    One week, one month and six months after surgery

  • Change in presence of sensitivity alteration

    Patients were asked to indicate the presence or absence of sensitivity alteration.

    One week, one month and six months after surgery

  • Change in presence of thrombophlebitis

    Physicians were asked to inform the presence or absence of thrombophlebitis.

    One week, one month and six months after surgery

  • Change in presence of resection or occlusion of the great saphenous vein

    Duplex ultrasound scan was used to evaluate the presence or absence of resection or occlusion (success rate) of the great saphenous vein.

    One month, six months and 12 months after surgery

  • Change in presence of reflux in the sapheno-femoral junction and in the great saphenous vein

    Duplex ultrasound scan was used to evaluate the presence or absence of reflux in the sapheno-femoral junction and in the great saphenous vein

    One month, six months and 12 months after surgery

  • Change in presence of complications

    Duplex ultrasound scan was used to evaluate the presence or absence of complications such as deep vein thrombosis (DVT) and lymphocele.

    One month, six months and 12 months after surgery

Study Arms (2)

Conventional Surgery

ACTIVE COMPARATOR

Limb with GSV insufficiency in the same patient, randomised to conventional surgery

Procedure: Conventional Surgery

Radiofrequency Ablation

ACTIVE COMPARATOR

Limb with GSV insufficiency in the same patient, randomised to radiofrequency ablation

Procedure: Radiofrequency Ablation

Interventions

Cranial ligation of the great saphenous vein and branches of the sapheno-femoral junction and stripping of the great saphenous vein

Conventional Surgery

Catheter-based ablation of the great saphenous vein

Radiofrequency Ablation

Eligibility Criteria

Age33 Years - 76 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 60 years
  • Clinical, etiologic, anatomic, pathophysiologic (CEAP): clinical grades 2 to 5 (C2-5), primary (Ep), superficial (As) and reflux only (Pr)
  • Duplex scan confirmed primary bilateral GSV insufficiency requiring surgery (insufficiency with reverse venous flow was regarded significant if persisting more than 0.5 seconds in a standing position)

You may not qualify if:

  • Patients able to give informed consent
  • Varicose veins without GSV insufficiency on duplex scan
  • Previous varicose vein surgery
  • Associated small saphenous vein reflux, duplication of the GSV at the SFJ, deep venous insufficiency or previous DVT on duplex scan
  • GSV diameter \<3 mm or \>12 mm in the supine position
  • Thrombus in the GSV
  • Patients with a pacemaker or internal defibrillator
  • Concomitant peripheral arterial disease (ankle-brachial pressure index of \<0.9)
  • Patients on oral anticoagulants
  • Patients with high blood pressure not controlled by medication
  • Patients with known thrombophilia, cancer or lupus
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Israelita Albert Einstein

São Paulo, São Paulo, Brazil

Location

Related Publications (6)

  • Wittens C, Davies AH, Baekgaard N, Broholm R, Cavezzi A, Chastanet S, de Wolf M, Eggen C, Giannoukas A, Gohel M, Kakkos S, Lawson J, Noppeney T, Onida S, Pittaluga P, Thomis S, Toonder I, Vuylsteke M, Esvs Guidelines Committee, Kolh P, de Borst GJ, Chakfe N, Debus S, Hinchliffe R, Koncar I, Lindholt J, de Ceniga MV, Vermassen F, Verzini F, Document Reviewers, De Maeseneer MG, Blomgren L, Hartung O, Kalodiki E, Korten E, Lugli M, Naylor R, Nicolini P, Rosales A. Editor's Choice - Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2015 Jun;49(6):678-737. doi: 10.1016/j.ejvs.2015.02.007. Epub 2015 Apr 25. No abstract available.

    PMID: 25920631BACKGROUND
  • Siribumrungwong B, Noorit P, Wilasrusmee C, Attia J, Thakkinstian A. A systematic review and meta-analysis of randomised controlled trials comparing endovenous ablation and surgical intervention in patients with varicose vein. Eur J Vasc Endovasc Surg. 2012 Aug;44(2):214-23. doi: 10.1016/j.ejvs.2012.05.017. Epub 2012 Jun 15.

    PMID: 22705163BACKGROUND
  • Hinchliffe RJ, Ubhi J, Beech A, Ellison J, Braithwaite BD. A prospective randomised controlled trial of VNUS closure versus surgery for the treatment of recurrent long saphenous varicose veins. Eur J Vasc Endovasc Surg. 2006 Feb;31(2):212-8. doi: 10.1016/j.ejvs.2005.07.005. Epub 2005 Aug 31.

    PMID: 16137898BACKGROUND
  • Goode SD, Chowdhury A, Crockett M, Beech A, Simpson R, Richards T, Braithwaite BD. Laser and radiofrequency ablation study (LARA study): a randomised study comparing radiofrequency ablation and endovenous laser ablation (810 nm). Eur J Vasc Endovasc Surg. 2010 Aug;40(2):246-53. doi: 10.1016/j.ejvs.2010.02.026.

    PMID: 20537570BACKGROUND
  • Subramonia S, Lees T. Radiofrequency ablation vs conventional surgery for varicose veins - a comparison of treatment costs in a randomised trial. Eur J Vasc Endovasc Surg. 2010 Jan;39(1):104-11. doi: 10.1016/j.ejvs.2009.09.012. Epub 2009 Oct 29.

    PMID: 19879166BACKGROUND
  • Mendes CA, Martins AA, Fukuda JM, Parente JB, Munia MA, Fioranelli A, Teivelis MP, Varella AY, Caffaro RA, Kuzniec S, Wolosker N. Randomized trial of radiofrequency ablation versus conventional surgery for superficial venous insufficiency: if you don't tell, they won't know. Clinics (Sao Paulo). 2016 Nov 1;71(11):650-656. doi: 10.6061/clinics/2016(11)06.

MeSH Terms

Conditions

Venous Insufficiency

Interventions

Radiofrequency Ablation

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Radiofrequency TherapyTherapeuticsAblation TechniquesSurgical Procedures, Operative

Study Officials

  • Nelson Wolosker, MD, PhD

    Hospital Israelita Albert Einstein

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

October 20, 2015

First Posted

October 28, 2015

Study Start

November 1, 2013

Primary Completion

May 1, 2015

Study Completion

October 1, 2015

Last Updated

October 28, 2015

Record last verified: 2015-10

Locations